155 related articles for article (PubMed ID: 28494780)
1. Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
Teyssonneau D; Daste A; Dousset V; Hoepffner JL; Ravaud A; Gross-Goupil M
BMC Cancer; 2017 May; 17(1):323. PubMed ID: 28494780
[TBL] [Abstract][Full Text] [Related]
2. [Non-muscle invasive bladder cancer with multiple bone metastasis without local invasion : a case report].
Sasaki Y; Oi H; Oyama T; Kagawa J; Komori M; Senzaki T; Fukawa T; Takahashi H; Takemura M; Yamaguchi K; Yamamoto Y; Izaki H; Takahashi M; Fukumori T; Kanayama HO
Hinyokika Kiyo; 2013 Oct; 59(10):669-72. PubMed ID: 24262709
[TBL] [Abstract][Full Text] [Related]
3. Meningeal carcinomatosis from transitional cell carcinoma of the bladder.
Eng C; Cunningham D; Quade BJ; Schwamm L; Kantoff PW; Skarin AT
Cancer; 1993 Jul; 72(2):553-7. PubMed ID: 8319186
[TBL] [Abstract][Full Text] [Related]
4. Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review.
Shelley MD; Jones G; Cleves A; Wilt TJ; Mason MD; Kynaston HG
BJU Int; 2012 Feb; 109(4):496-505. PubMed ID: 22313502
[TBL] [Abstract][Full Text] [Related]
5. The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial.
Daneshmand S; Brummelhuis ISG; Pohar KS; Steinberg GD; Aron M; Cutie CJ; Keegan KA; Maffeo JC; Reynolds DL; Raybold B; Chau A; Witjes JA
Urol Oncol; 2022 Jul; 40(7):344.e1-344.e9. PubMed ID: 35431132
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine, Cisplatin, and sunitinib for metastatic urothelial carcinoma and as preoperative therapy for muscle-invasive bladder cancer.
Galsky MD; Hahn NM; Powles T; Hellerstedt BA; Lerner SP; Gardner TA; Yu M; O'Rourke M; Vogelzang NJ; Kocs D; McKenney SA; Melnyk AM; Hutson TE; Rauch M; Wang Y; Asmar L; Sonpavde G
Clin Genitourin Cancer; 2013 Jun; 11(2):175-81. PubMed ID: 23228446
[TBL] [Abstract][Full Text] [Related]
7. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
[TBL] [Abstract][Full Text] [Related]
8. Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy.
North S; El-Gehani F; Santos C; Ghosh S; Lai R; Cass CE; Mackey JR
J Urol; 2014 Jan; 191(1):35-9. PubMed ID: 23851183
[TBL] [Abstract][Full Text] [Related]
9. Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis.
Yamada T; Ohtsubo K; Mouri H; Yamashita K; Yasumoto K; Izumi K; Zen Y; Watanabe H; Yano S
Int J Clin Oncol; 2009 Oct; 14(5):468-72. PubMed ID: 19856060
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study.
Necchi A; Lo Vullo S; Raggi D; Perrone F; Giannatempo P; Calareso G; Togliardi E; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Colecchia M; Busico A; Pennati M; Zaffaroni N; Mariani L; Salvioni R
Urol Oncol; 2018 Jan; 36(1):8.e1-8.e8. PubMed ID: 28911922
[TBL] [Abstract][Full Text] [Related]
11. Intravesical gemcitabine for non-muscle invasive bladder cancer.
Jones G; Cleves A; Wilt TJ; Mason M; Kynaston HG; Shelley M
Cochrane Database Syst Rev; 2012 Jan; 1():CD009294. PubMed ID: 22259002
[TBL] [Abstract][Full Text] [Related]
12. [A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin].
Ishii M; Yamamoto Y; Yoshimura A; Hayashi T; Kawamura N; Nagahara A; Nakai Y; Nakayama M; Nishimura K
Hinyokika Kiyo; 2023 Apr; 69(4):107-112. PubMed ID: 37183041
[TBL] [Abstract][Full Text] [Related]
13. A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder.
DeCastro GJ; Sui W; Pak JS; Lee SM; Holder D; Kates MM; Virk RK; Drake CG; Anderson CB; James B; Abate-Shen CT; McKiernan JM
J Urol; 2020 Aug; 204(2):247-253. PubMed ID: 32118506
[TBL] [Abstract][Full Text] [Related]
14. The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): a new treatment option for invasive bladder cancer patients with lymph node metastasis.
Azuma H; Inamoto T; Takahara K; Nomi H; Hirano H; Ibuki N; Uehara H; Komura K; Minami K; Uchimoto T; Saito K; Takai T; Tanda N; Yamamoto K; Narumi Y; Kiyama S
Int J Oncol; 2014 Jun; 44(6):1895-903. PubMed ID: 24728124
[TBL] [Abstract][Full Text] [Related]
15. [Metastatic micropapillary variant of urothelial carcinoma of the urinary bladder responding to gemcitabine and cisplatin chemotherapy].
Ishii T; Matsubara T; Taira H; Hiratsuka Y
Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):540-4. PubMed ID: 23819368
[TBL] [Abstract][Full Text] [Related]
16. [The Combination Therapy of Gemcitabine Plus Paclitaxel Induced Complete Response in a Tongue Skin Brain Metastasis of Bladder Carcinoma: A Case Report].
Uemura Y; Ushida H; Ishitoya S; Onishi H; Terashima T; Takeuchi E
Hinyokika Kiyo; 2015 Oct; 61(10):405-9. PubMed ID: 26563624
[TBL] [Abstract][Full Text] [Related]
17. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.
Pfister C; Gravis G; Fléchon A; Soulié M; Guy L; Laguerre B; Mottet N; Joly F; Allory Y; Harter V; Culine S;
Eur Urol; 2021 Feb; 79(2):214-221. PubMed ID: 32868138
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation.
Khaled HM; Shafik HE; Zabhloul MS; Ghoneim M; Saber RA; Manie M; Enein HA; Megeed HA; Mansur O; Sherbini ME; Mahran TZ; Kalawee ME; Badran A; Ramadan SM
Clin Genitourin Cancer; 2014 Oct; 12(5):e233-40. PubMed ID: 24889794
[TBL] [Abstract][Full Text] [Related]
19. [Metastases of Urothelial Carcinoma with Trophoblastic Differentiation that Responded to Combination Chemotherapy with Gemcitabine and Oxaliplatin : A Case Report].
Uchida M; Kawai K; Kurobe M; Ikeda A; Kandori S; Endo T; Miyagawa T; Kojima T; Tsutsumi M; Nishiyama H
Hinyokika Kiyo; 2018 Feb; 64(2):55-61. PubMed ID: 29684950
[TBL] [Abstract][Full Text] [Related]
20. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
